#VisualAbstract: Stereotactic body radiotherapy enhances survival in patients with non-small cell lung cancer

1. Median progression-free survival was greater in the SBRT group than in the standard-of-care group. 2. Patients with NSCLC displayed a significant survival benefit with SBRT in comparison to patients with breast cancer. Evidence Rating Level: 1 (Excellent) Study Rundown: Most patients with metastatic breast cancer develop resistance to systemic therapy. Stereotactic body radiotherapy (SBRT) is a

Related Keywords

United States , ,Minute Medicine Inc ,Rating Level ,Breast Conserving Surgery ,Early Breast ,Between Jan ,Breast Cancer ,Cancer ,Lung Cancer ,Metastatic Breast Cancer ,Non Small Cell Lung Cancer ,Nsclc ,Radiotherapy ,Sbrt ,Stereotactic Body Radiotherapy ,Studygraphics ,